American journal of hematology

Keyphrases

Publications

volume 99, number 8, 2024

Ayalew Tefferi, Animesh D Pardanani, Naseema Gangat
Treatment-associated decline in JAK2V617F allele burden in polycythemia vera: What does it mean? American journal of hematology 99 (8) (2024)
Caleb J Smith, Gordon J Ruan, Lindsey Ann Kluck, Mackenzie Maberry, Ronald S Go
BCR-ABL testing in the evaluation of neutrophilia. American journal of hematology 99 (8) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Ahlem Achour, Jeroen Knijnenburg, Tamara Koopmann, Amir Raz, Marc Tischkowitz, Thomas D Coates, F Baas, C L Harteveld
Moderate-severe beta-thalassemia intermedia phenotype caused by sextuplicated alpha-globin gene allele in two beta-thalassemia carriers. American journal of hematology 99 (8) (2024)
Kirsteen Harper, Gillian Horne, Mike Leach, BarbaraJ J Bain
From the eosinophil to a novel FGFR1 fusion gene. American journal of hematology 99 (8) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Brunangelo Falini, Patrizia Chiusolo, Luana Fianchi, Livio Pagano
NPM1-mutated myeloid neoplasm with low percentage of blasts. American journal of hematology 99 (8) (2024)
Aseel Alsouqi, Gulrayz Ahmed, Juntian Wang, Giulio Cassanello, Aniko Szabo, Alexandra E Rojek, Peter A Riedell, Farrukh T Awan, Laura Samples, Mazyar Shadman, Marie Hu, Veronika Bachanova, William Wesson, Nausheen Ahmed, Madiha Iqbal, Mohamed A Kharfan-Dabaja, Michael Scordo, P Connor Johnson, Yi-Bin Chen, Sawa Ito, Mehdi Hamadani, Matthew Frigault
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis. American journal of hematology 99 (8) (2024)
Marc Michel, M Saïr, E Rivière, G Moulis, Thibault Comont, N Costedoat-Chalumeau, C Pouchelon, David Boutboul, A Benyamine, A Bert, P-Y Jeandel, S Hamrouni, N Belfeki, Hervé Lobbes, A Dossier, D Gobert, Matthieu Mahevas, B Godeau, Y Gallien, M Ebbo
Intravenous immunoglobulin as a rescue therapy for severe adult autoimmune hemolytic anemia: Results from a French multicenter observational study. American journal of hematology 99 (8) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Brunangelo Falini, Patrizia Chiusolo, Luana Fianchi, Livio Pagano
NPM1-mutated myeloid neoplasm with low percentage of blasts. American journal of hematology 99 (8) (2024)
Matthew James Rees, Shaji K Kumar
High-risk multiple myeloma: Redefining genetic, clinical, and functional high-risk disease in the era of molecular medicine and immunotherapy. American journal of hematology 99 (8) (2024)
Camille Kockerols, Peter J M Valk, Stephanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo B Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis. American journal of hematology 99 (8) (2024)
Bianca Rocca, Alberto Tosetto, Giovanna Petrucci, Elena Rossi, Silvia Betti, Denise Soldati, Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, Alfredo Dragani, Mauro Di Ianni, Paola Ranalli, Francesca Palandri, Nicola Vianelli, Eloise Beggiato, Giuseppe Lanzarone, Marco Ruggeri, Giuseppe Carli, Elena Maria Elli, Rossella Renso, Maria Luigia Randi, Irene Bertozzi, Giuseppe Gaetano Loscocco, Alessandra Ricco, Giorgina Specchia, Alessandro Maria Maria Vannucchi, Francesco Rodeghiero, Valerio De Stefano, Carlo Patrono, null null
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial. American journal of hematology 99 (8) (2024)
Kirsteen Harper, Gillian Horne, Mike Leach, BarbaraJ J Bain
From the eosinophil to a novel FGFR1 fusion gene. American journal of hematology 99 (8) (2024)
Tamer Othman, Shanpeng Li, Jianying Zhang, Hoda Z Pourhassan, Vaibhav Agrawal, Dat Ngo, Jason Chen, Leonardo Farol, Firoozeh Sahebi, Karamjeet Sandhu, Ricardo Spielberger, Guido Marcucci, Stephen J Forman, Anthony S Stein, Ryotaro Nakamura, Vinod A Pullarkat, Matthew G Mei, Ibrahim Aldoss, Paul B Koller
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia. American journal of hematology 99 (8) (2024)
Ahlem Achour, Jeroen Knijnenburg, Tamara Koopmann, Amir Raz, Marc Tischkowitz, Thomas D Coates, F Baas, C L Harteveld
Moderate-severe beta-thalassemia intermedia phenotype caused by sextuplicated alpha-globin gene allele in two beta-thalassemia carriers. American journal of hematology 99 (8) (2024)
Camille Kockerols, Peter J M Valk, Stephanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo B Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis. American journal of hematology 99 (8) (2024)
Ayalew Tefferi, Animesh D Pardanani, Naseema Gangat
Treatment-associated decline in JAK2V617F allele burden in polycythemia vera: What does it mean? American journal of hematology 99 (8) (2024)
Aditi Manjeri, Shir Ying Lee, Siok-Bian Ng, Chun-Tsu Lee
Plasmablastic lymphoma in the pleural cavity. American journal of hematology 99 (8) (2024)
Aseel Alsouqi, Gulrayz Ahmed, Juntian Wang, Giulio Cassanello, Aniko Szabo, Alexandra E Rojek, Peter A Riedell, Farrukh T Awan, Laura Samples, Mazyar Shadman, Marie Hu, Veronika Bachanova, William Wesson, Nausheen Ahmed, Madiha Iqbal, Mohamed A Kharfan-Dabaja, Michael Scordo, P Connor Johnson, Yi-Bin Chen, Sawa Ito, Mehdi Hamadani, Matthew Frigault
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis. American journal of hematology 99 (8) (2024)
Andres Ramirez-Gamero, Humberto Martínez-Cordero, Brady Ernesto Beltrán-Gárate, Jorge A Florindez, Luis E Malpica-Castillo, Jorge J Castillo
Plasmablastic lymphoma: 2024 update on diagnosis, risk stratification, and management. American journal of hematology 99 (8) (2024)
Tiziano Barbui
Paving the path for ongoing clinical research and education in post retirement age. American journal of hematology 99 (8) (2024)
Petra Langerbeins, Adam Giza, Sandra Robrecht, Paula Cramer, Julia von Tresckow, Othman Al-Sawaf, Anna Maria Fink, Moritz Fürstenau, Arnon P Kater, Ellen van der Spek, Carsten Utoft Niemann, Caspar da Cunha-Bang, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Kirsten Fischer, Michael Hallek, Barbara Eichhorst
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations. American journal of hematology 99 (8) (2024)
Elaine A Yu, Helena U Zacharias, Shannon Kelly, Elliott Vichinsky
Improving healthspan among people with sickle cell disease: Leveraging precision health in an era of treatments with curative intent. American journal of hematology 99 (8) (2024)
Ayalew Tefferi, Tiziano Barbui
Aspirin use in essential thrombocythemia: Once-daily or twice-daily or not at all? American journal of hematology 99 (8) (2024)
Gertjan Lugthart, E J T Verweij, C L Harteveld, R N G B Tan, M F C M Knapen, F Slaghekke, M C Haak, A B Mohseny, F J Smiers
Suppression of Hb Bart's to improve tissue oxygenation and fetal development in homozygous alpha-thalassemia. American journal of hematology 99 (8) (2024)

volume 99, number 9, 2024

David J Young
A growing panoply of options for patients with paroxysmal nocturnal hemoglobinuria. American journal of hematology 99 (9) (2024)
Phillip Scheinberg, Diego Villa Clé, Jin Seok Kim, Erfan Nur, Mustafa N Yenerel, Wilma Barcellini, Debora Bonito, Valentina Giai, Marek Hus, YooJin Lee, Cristina Barrenetxea Lekue, Jens Peter Panse, Yasutaka Ueda, Simon Buatois, Brittany Gentile, Anna Kiialainen, Himika Patel, Sasha Sreckovic, Marianne Uguen, John Edwards, Zsolt Nagy, Austin G Kulasekararaj
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria. American journal of hematology 99 (9) (2024)
Claudia Pérez-Carretero, Teresa González, Miguel Quijada Álamo, Gian Matteo Rigolin, Adrian Dubuc, Ángela Villaverde Ramiro, Alberto Rodríguez-Sánchez, Araceli Rubio, Julio Dávila-Valls, Mª Jesús Vidal, Isabel González-Gascón Y Marín, José-Ángel Hernández-Rivas, Rocío Benito, Virginia Volpe, Matthew S Davids, Jeremy S Abramson, Antonio Cuneo, Paola Dal Cin, Ana Eugenia Rodríguez Vicente, Jesús María Hernández-Rivas
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis. American journal of hematology 99 (9) (2024)
Lauren Véronèse, Hedi Bensaber, Louis-Thomas Dannus, Gaetan Giannone, Christopher Choiset, Corentin Grimpret, Nassera Abermil, Estelle Balducci, Audrey Bidet, Elise Chapiro, Lucile Couronné, Agnès Daudignon, Nathalie Douet-Gilbert, Virginie Eclache, Baptiste Gaillard, Jean-Baptiste Gaillard, Faten Hsoumi, Christine Lefebvre, Nathalie Nadal, Marie-Joelle Mozziconacci, Dominique Penther, Bénédicte Ribourtout, Steven Richebourg, Lauren Rigollet, Christine Terre, Gwendoline Soler, Olivier Tournilhac, Romain Guièze, Florence Nguyen-Khac, Andrei Tchirkov
Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study. American journal of hematology 99 (9) (2024)
Karin Bauer, Alexander Hauswirth, Karoline V Gleixner, Georg Greiner, Johannes Thaler, Peter Bettelheim, Yüksel Filik, Elisabeth Koller, Gregor Hoermann, Philipp B Staber, Wolfgang R Sperr, Felix Keil, Peter Valent
BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL. American journal of hematology 99 (9) (2024)
Abdalla Dikair, Kirsteen Harper, Mike Leach, BarbaraJ J Bain
Accurate identification of a precursor B-cell neoplasm. American journal of hematology 99 (9) (2024)
Hazim S Ababneh, Andrea K Ng, Matthew J Frigault, Caron A Jacobson, Chirayu G Patel
Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy. American journal of hematology 99 (9) (2024)
Sundararajan Vincent Rajkumar
Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. American journal of hematology 99 (9) (2024)
Sosana Delimpasi, Meletios- Athanasios Dimopoulos, Jan Straub, Argiris Symeonidis, Luděk Pour, Roman Hájek, Cyrille Touzeau, Viralkumar K Bhanderi, Jesus G Berdeja, Petr Pavlíček, Jeffrey V Matous, Pawel J Robak, Kaveri Suryanarayan, Alison Miller, Miguel Villarreal, Dasha Cherepanov, Jaydeep K Srimani, Huilan Yao, Richard Labotka, Robert Z Orlowski
Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma. American journal of hematology 99 (9) (2024)
Naseema Gangat, Ayalew Tefferi
Targeting anemia in myeloid neoplasms. American journal of hematology 99 (9) (2024)
Tamer Othman, Paul B Koller, Ni-Chun Tsai, Dongyun Yang, Hoda Z Pourhassan, Vaibhav Agrawal, Dat Ngo, Jason Chen, Leonardo Farol, Ricardo Spielberger, Firoozeh Sahebi, Monzr M Al Malki, Ji-Lian Cai, Karamjeet S Sandhu, Joshua Mansour, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Shukaib Arslan, Guido Marcucci, Stephen J Forman, Anthony S Stein, Ryotaro Nakamura, Vinod A Pullarkat, Ibrahim Aldoss, Matthew G Mei
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. American journal of hematology 99 (9) (2024)
Yanmeng Li, Anjian Xu, Susu Liu, Wei Zhang, Donghu Zhou, Qin OuYang, Huaduan Zi, Bei Zhang, Ning Zhang, Wei Geng, Yiming Zhou, Weijia Duan, Xiaoming Wang, Xinyan Zhao, Xiaojuan Ou, Changfa Fan, Jidong Jia, Jian Huang
SUGP2 p.(Arg639Gln) variant is involved in the pathogenesis of hemochromatosis via the CIRBP/BMPER signaling pathway. American journal of hematology 99 (9) (2024)
Calia A Morais, Najibah A Galadanci, Jeremy Osborn, Julie Kanter
Real-world implementation of the David-Carroll buprenorphine protocol for pain management in sickle cell disease. American journal of hematology 99 (9) (2024)
Xi Zhang, Yi Ding, Peng Li, Kirk Bourgeois, Aruna Rangan, Jennifer L Herrick, Animesh D Pardanani, Dong Chen, David Viswanatha, Rong He, Gang Zheng
Null-type SH2B3 mutations are potential drivers in a subset of Ph-negative myeloproliferative neoplasms. American journal of hematology 99 (9) (2024)
Aung Myint Tun, Romil D Patel, Frederique St-Pierre, Evguenia Ouchveridze, Alex Niu, Thorunn Thordardottir, Jennifer Obasi, Allison C Rosenthal, Priyanka A Pophali, Timothy S Fenske, Reem Karmali, Sairah Ahmed, Patrick B Johnston
Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study. American journal of hematology 99 (9) (2024)
Sundararajan Vincent Rajkumar
Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. American journal of hematology 99 (9) (2024)
Moshe Mittelman, David H Henry, John A Glaspy, Anil Tombak, Rosemary Harrup, Inho Kim, Krzysztof Mądry, Barbara Grabowska, Tyson Lee, Katharina Modelska
Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial. American journal of hematology 99 (9) (2024)
Jennifer Marvin-Peek, Jason S Gilbert, Daniel A Pollyea, Courtney D D DiNardo
Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go? American journal of hematology 99 (9) (2024)
Alexander Röth, Guang-Sheng He, Hongyan Tong, Zenghua Lin, Xiaoqin Wang, Chatree Chai-Adisaksopha, Je Hwan Lee, Andres Brodsky, Chattree Hantaweepant, Teresita E Dumagay, Roberta Demichelis-Gómez, Ponlapat Rojnuckarin, Jing Sun, Martin Höglund, Jun Ho Jang, Anna Gaya, Fernando Silva, Naoshi Obara, Richard J Kelly, Leigh Beveridge, Simon Buatois, Sammy Chebon, Brittany Gentile, Pontus Lundberg, Sasha Sreckovic, Jun-Ichi Nishimura, Antonio Maria Risitano, Bing Han
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition. American journal of hematology 99 (9) (2024)
Arnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, Myriam Labopin, Igor Wolfgang Blau, Nicolaus Kröger, Tobias Gedde-Dahl, Thomas Schroeder, David Burns, Urpu Salmenniemi, Alessandro Rambaldi, Goda Choi, Regis Peffault de Latour, Jan Vydra, Henrik Sengeløv, Matthias Eder, Stephan Mielke, Edouard Forcade, Alexander Dmitrievich Kulagin, Fabio Ciceri, Mohamad Mohty
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. American journal of hematology 99 (9) (2024)
Fakiha Siddiqui, Alfonso Tafur, Mushtaq Hussain, Alberto García-Ortega, Amir Darki, Jawed Fareed, David Jiménez, Behnood Bikdeli, Francisco Galeano-Valle, José Luis Fernández-Reyes, Montserrat Pérez-Pinar, Manuel Monreal, null null
The prognostic value of blood cellular indices in pulmonary embolism. American journal of hematology 99 (9) (2024)
Valentine Brousse, Sara El Hoss, Pierre Isnard, Sandrine Laurance, Camille Lambert, Liza Ali, Arnaud Bonnard, Carmen Capito, Sabine Sarnacki, D Berrebi, Berengère Koehl, Malika Benkerrou, Florence Missud, Laurent Holvoet, Ghislaine Ithier, Mariane De Montalembert, Slimane Allali, Mariane de Montalembert, Jacques Diebold, Thierry Jo Molina
Comparative histological analysis of spleens in pediatric patients with hemolytic anemias: Insights into the pathophysiological mechanisms of spleen destruction in sickle cell anemia. American journal of hematology 99 (9) (2024)
Fnu Sameeta, Hong Fang, Wei Wang, Zhenya Tang, Sa A Wang, Gokce A Toruner, Xenia Parisi, Joseph D Khoury, Ghayas C Issa, Guillermo Garcia Manero, L Jeffrey Medeiros, Guillin Tang, Sanam Loghavi
Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma. American journal of hematology 99 (9) (2024)